Ryan is Program Director and Partner at IndieBio, where he oversees development of the IndieBio ecosystem of founders, investors, mentors and partners. He leads program design and implementation for IndieBio, including recruitment, due diligence, fundraising, curriculum design, and program delivery.
Ryan has worked over the last decade in the biopharmaceutical industry to partner on and develop novel drugs from first IND submission to FDA approval with many major biopharmas including Pfizer, AZ, J&J, Sanofi, Takeda, Amgen, Genentech, and other companies in the U.S., E.U., and Japan. He’s also served as COO at Genescient Pharmaceuticals, a longevity-focused biotech startup, and CEO of Halpin Neurosciences, an ALS-focused startup. He was previously the Life Sciences head at the XPRIZE Foundation, the co-founder and CEO of Berkeley Biolabs and the co-founder of Sudo Roomand Counter Culture Labs, where he still retains a board seat.
Ryan’s work has been featured in Wired, TechCrunch, Forbes, the San Francisco Business Times, and other publications. He regularly speaks on biotech innovation and writes for Biocoder, an O’Reilly Media publication.
SOSV Blog Posts by Ryan: